Global AAV-based Gene Therapy Products Market Research Report 2025(Status and Outlook)
Report Overview
AAV-based gene therapy products utilize adeno-associated virus (AAV) vectors as delivery vehicles to transfer therapeutic genes into target cells for the treatment of various genetic disorders and diseases. AAV vectors are non-pathogenic viruses that can efficiently infect a wide range of cells and have a low immunogenicity profile, making them suitable candidates for gene therapy applications. In AAV-based gene therapy, the therapeutic gene of interest is inserted into the AAV vector's genome, and the vector is then administered to the patient, typically via intravenous injection or direct injection into the affected tissue. Once inside the target cells, the AAV vector delivers the therapeutic gene, allowing it to be expressed and produce the desired therapeutic protein. AAV-based gene therapy products hold significant promise for the treatment of inherited genetic disorders, as well as acquired diseases such as certain types of cancer and neurodegenerative disorders, offering potential long-term therapeutic benefits with a single administration.
This report provides a deep insight into the global AAV-based Gene Therapy Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global AAV-based Gene Therapy Products Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the AAV-based Gene Therapy Products market in any manner.
Global AAV-based Gene Therapy Products Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
uniQure
Spark Therapeutics
AveXis (Novartis)
PTC Therapeutics
BioMarin
Sarepta Therapeutics
Roche
Pfizer
CSL Behring
Sangamo Therapeutics
Biogen
Freeline Therapeutics
Coave Therapeutics
MeiraGTx
RegenxBio
Asklepios Biopharmaceutical
Audentes Therapeutics
Neurophth
Belief BioMed
Market Segmentation (by Type)
AAV2
AAV8
AAV9
Others
Market Segmentation (by Application)
Haematology
Ophthalmology
Neurology
Musculoskeletal
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AAV-based Gene Therapy Products Market
Overview of the regional outlook of the AAV-based Gene Therapy Products Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AAV-based Gene Therapy Products Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AAV-based Gene Therapy Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
AAV-based gene therapy products utilize adeno-associated virus (AAV) vectors as delivery vehicles to transfer therapeutic genes into target cells for the treatment of various genetic disorders and diseases. AAV vectors are non-pathogenic viruses that can efficiently infect a wide range of cells and have a low immunogenicity profile, making them suitable candidates for gene therapy applications. In AAV-based gene therapy, the therapeutic gene of interest is inserted into the AAV vector's genome, and the vector is then administered to the patient, typically via intravenous injection or direct injection into the affected tissue. Once inside the target cells, the AAV vector delivers the therapeutic gene, allowing it to be expressed and produce the desired therapeutic protein. AAV-based gene therapy products hold significant promise for the treatment of inherited genetic disorders, as well as acquired diseases such as certain types of cancer and neurodegenerative disorders, offering potential long-term therapeutic benefits with a single administration.
This report provides a deep insight into the global AAV-based Gene Therapy Products market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global AAV-based Gene Therapy Products Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the AAV-based Gene Therapy Products market in any manner.
Global AAV-based Gene Therapy Products Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
uniQure
Spark Therapeutics
AveXis (Novartis)
PTC Therapeutics
BioMarin
Sarepta Therapeutics
Roche
Pfizer
CSL Behring
Sangamo Therapeutics
Biogen
Freeline Therapeutics
Coave Therapeutics
MeiraGTx
RegenxBio
Asklepios Biopharmaceutical
Audentes Therapeutics
Neurophth
Belief BioMed
Market Segmentation (by Type)
AAV2
AAV8
AAV9
Others
Market Segmentation (by Application)
Haematology
Ophthalmology
Neurology
Musculoskeletal
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AAV-based Gene Therapy Products Market
Overview of the regional outlook of the AAV-based Gene Therapy Products Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AAV-based Gene Therapy Products Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AAV-based Gene Therapy Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of AAV-based Gene Therapy Products
1.2 Key Market Segments
1.2.1 AAV-based Gene Therapy Products Segment by Type
1.2.2 AAV-based Gene Therapy Products Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AAV-BASED GENE THERAPY PRODUCTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AAV-based Gene Therapy Products Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global AAV-based Gene Therapy Products Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AAV-BASED GENE THERAPY PRODUCTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AAV-based Gene Therapy Products Product Life Cycle
3.3 Global AAV-based Gene Therapy Products Sales by Manufacturers (2020-2025)
3.4 Global AAV-based Gene Therapy Products Revenue Market Share by Manufacturers (2020-2025)
3.5 AAV-based Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global AAV-based Gene Therapy Products Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 AAV-based Gene Therapy Products Market Competitive Situation and Trends
3.8.1 AAV-based Gene Therapy Products Market Concentration Rate
3.8.2 Global 5 and 10 Largest AAV-based Gene Therapy Products Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AAV-BASED GENE THERAPY PRODUCTS INDUSTRY CHAIN ANALYSIS
4.1 AAV-based Gene Therapy Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AAV-BASED GENE THERAPY PRODUCTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AAV-based Gene Therapy Products Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to AAV-based Gene Therapy Products Market
5.7 ESG Ratings of Leading Companies
6 AAV-BASED GENE THERAPY PRODUCTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AAV-based Gene Therapy Products Sales Market Share by Type (2020-2025)
6.3 Global AAV-based Gene Therapy Products Market Size Market Share by Type (2020-2025)
6.4 Global AAV-based Gene Therapy Products Price by Type (2020-2025)
7 AAV-BASED GENE THERAPY PRODUCTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AAV-based Gene Therapy Products Market Sales by Application (2020-2025)
7.3 Global AAV-based Gene Therapy Products Market Size (M USD) by Application (2020-2025)
7.4 Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
8 AAV-BASED GENE THERAPY PRODUCTS MARKET SALES BY REGION
8.1 Global AAV-based Gene Therapy Products Sales by Region
8.1.1 Global AAV-based Gene Therapy Products Sales by Region
8.1.2 Global AAV-based Gene Therapy Products Sales Market Share by Region
8.2 Global AAV-based Gene Therapy Products Market Size by Region
8.2.1 Global AAV-based Gene Therapy Products Market Size by Region
8.2.2 Global AAV-based Gene Therapy Products Market Size Market Share by Region
8.3 North America
8.3.1 North America AAV-based Gene Therapy Products Sales by Country
8.3.2 North America AAV-based Gene Therapy Products Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe AAV-based Gene Therapy Products Sales by Country
8.4.2 Europe AAV-based Gene Therapy Products Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific AAV-based Gene Therapy Products Sales by Region
8.5.2 Asia Pacific AAV-based Gene Therapy Products Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America AAV-based Gene Therapy Products Sales by Country
8.6.2 South America AAV-based Gene Therapy Products Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa AAV-based Gene Therapy Products Sales by Region
8.7.2 Middle East and Africa AAV-based Gene Therapy Products Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AAV-BASED GENE THERAPY PRODUCTS MARKET PRODUCTION BY REGION
9.1 Global Production of AAV-based Gene Therapy Products by Region(2020-2025)
9.2 Global AAV-based Gene Therapy Products Revenue Market Share by Region (2020-2025)
9.3 Global AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America AAV-based Gene Therapy Products Production
9.4.1 North America AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.4.2 North America AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe AAV-based Gene Therapy Products Production
9.5.1 Europe AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.5.2 Europe AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan AAV-based Gene Therapy Products Production (2020-2025)
9.6.1 Japan AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.6.2 Japan AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China AAV-based Gene Therapy Products Production (2020-2025)
9.7.1 China AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.7.2 China AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 uniQure
10.1.1 uniQure Basic Information
10.1.2 uniQure AAV-based Gene Therapy Products Product Overview
10.1.3 uniQure AAV-based Gene Therapy Products Product Market Performance
10.1.4 uniQure Business Overview
10.1.5 uniQure SWOT Analysis
10.1.6 uniQure Recent Developments
10.2 Spark Therapeutics
10.2.1 Spark Therapeutics Basic Information
10.2.2 Spark Therapeutics AAV-based Gene Therapy Products Product Overview
10.2.3 Spark Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.2.4 Spark Therapeutics Business Overview
10.2.5 Spark Therapeutics SWOT Analysis
10.2.6 Spark Therapeutics Recent Developments
10.3 AveXis (Novartis)
10.3.1 AveXis (Novartis) Basic Information
10.3.2 AveXis (Novartis) AAV-based Gene Therapy Products Product Overview
10.3.3 AveXis (Novartis) AAV-based Gene Therapy Products Product Market Performance
10.3.4 AveXis (Novartis) Business Overview
10.3.5 AveXis (Novartis) SWOT Analysis
10.3.6 AveXis (Novartis) Recent Developments
10.4 PTC Therapeutics
10.4.1 PTC Therapeutics Basic Information
10.4.2 PTC Therapeutics AAV-based Gene Therapy Products Product Overview
10.4.3 PTC Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.4.4 PTC Therapeutics Business Overview
10.4.5 PTC Therapeutics Recent Developments
10.5 BioMarin
10.5.1 BioMarin Basic Information
10.5.2 BioMarin AAV-based Gene Therapy Products Product Overview
10.5.3 BioMarin AAV-based Gene Therapy Products Product Market Performance
10.5.4 BioMarin Business Overview
10.5.5 BioMarin Recent Developments
10.6 Sarepta Therapeutics
10.6.1 Sarepta Therapeutics Basic Information
10.6.2 Sarepta Therapeutics AAV-based Gene Therapy Products Product Overview
10.6.3 Sarepta Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.6.4 Sarepta Therapeutics Business Overview
10.6.5 Sarepta Therapeutics Recent Developments
10.7 Roche
10.7.1 Roche Basic Information
10.7.2 Roche AAV-based Gene Therapy Products Product Overview
10.7.3 Roche AAV-based Gene Therapy Products Product Market Performance
10.7.4 Roche Business Overview
10.7.5 Roche Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer AAV-based Gene Therapy Products Product Overview
10.8.3 Pfizer AAV-based Gene Therapy Products Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 CSL Behring
10.9.1 CSL Behring Basic Information
10.9.2 CSL Behring AAV-based Gene Therapy Products Product Overview
10.9.3 CSL Behring AAV-based Gene Therapy Products Product Market Performance
10.9.4 CSL Behring Business Overview
10.9.5 CSL Behring Recent Developments
10.10 Sangamo Therapeutics
10.10.1 Sangamo Therapeutics Basic Information
10.10.2 Sangamo Therapeutics AAV-based Gene Therapy Products Product Overview
10.10.3 Sangamo Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.10.4 Sangamo Therapeutics Business Overview
10.10.5 Sangamo Therapeutics Recent Developments
10.11 Biogen
10.11.1 Biogen Basic Information
10.11.2 Biogen AAV-based Gene Therapy Products Product Overview
10.11.3 Biogen AAV-based Gene Therapy Products Product Market Performance
10.11.4 Biogen Business Overview
10.11.5 Biogen Recent Developments
10.12 Freeline Therapeutics
10.12.1 Freeline Therapeutics Basic Information
10.12.2 Freeline Therapeutics AAV-based Gene Therapy Products Product Overview
10.12.3 Freeline Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.12.4 Freeline Therapeutics Business Overview
10.12.5 Freeline Therapeutics Recent Developments
10.13 Coave Therapeutics
10.13.1 Coave Therapeutics Basic Information
10.13.2 Coave Therapeutics AAV-based Gene Therapy Products Product Overview
10.13.3 Coave Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.13.4 Coave Therapeutics Business Overview
10.13.5 Coave Therapeutics Recent Developments
10.14 MeiraGTx
10.14.1 MeiraGTx Basic Information
10.14.2 MeiraGTx AAV-based Gene Therapy Products Product Overview
10.14.3 MeiraGTx AAV-based Gene Therapy Products Product Market Performance
10.14.4 MeiraGTx Business Overview
10.14.5 MeiraGTx Recent Developments
10.15 RegenxBio
10.15.1 RegenxBio Basic Information
10.15.2 RegenxBio AAV-based Gene Therapy Products Product Overview
10.15.3 RegenxBio AAV-based Gene Therapy Products Product Market Performance
10.15.4 RegenxBio Business Overview
10.15.5 RegenxBio Recent Developments
10.16 Asklepios Biopharmaceutical
10.16.1 Asklepios Biopharmaceutical Basic Information
10.16.2 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Overview
10.16.3 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Market Performance
10.16.4 Asklepios Biopharmaceutical Business Overview
10.16.5 Asklepios Biopharmaceutical Recent Developments
10.17 Audentes Therapeutics
10.17.1 Audentes Therapeutics Basic Information
10.17.2 Audentes Therapeutics AAV-based Gene Therapy Products Product Overview
10.17.3 Audentes Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.17.4 Audentes Therapeutics Business Overview
10.17.5 Audentes Therapeutics Recent Developments
10.18 Neurophth
10.18.1 Neurophth Basic Information
10.18.2 Neurophth AAV-based Gene Therapy Products Product Overview
10.18.3 Neurophth AAV-based Gene Therapy Products Product Market Performance
10.18.4 Neurophth Business Overview
10.18.5 Neurophth Recent Developments
10.19 Belief BioMed
10.19.1 Belief BioMed Basic Information
10.19.2 Belief BioMed AAV-based Gene Therapy Products Product Overview
10.19.3 Belief BioMed AAV-based Gene Therapy Products Product Market Performance
10.19.4 Belief BioMed Business Overview
10.19.5 Belief BioMed Recent Developments
11 AAV-BASED GENE THERAPY PRODUCTS MARKET FORECAST BY REGION
11.1 Global AAV-based Gene Therapy Products Market Size Forecast
11.2 Global AAV-based Gene Therapy Products Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AAV-based Gene Therapy Products Market Size Forecast by Country
11.2.3 Asia Pacific AAV-based Gene Therapy Products Market Size Forecast by Region
11.2.4 South America AAV-based Gene Therapy Products Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of AAV-based Gene Therapy Products by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global AAV-based Gene Therapy Products Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of AAV-based Gene Therapy Products by Type (2026-2033)
12.1.2 Global AAV-based Gene Therapy Products Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of AAV-based Gene Therapy Products by Type (2026-2033)
12.2 Global AAV-based Gene Therapy Products Market Forecast by Application (2026-2033)
12.2.1 Global AAV-based Gene Therapy Products Sales (K Units) Forecast by Application
12.2.2 Global AAV-based Gene Therapy Products Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of AAV-based Gene Therapy Products
1.2 Key Market Segments
1.2.1 AAV-based Gene Therapy Products Segment by Type
1.2.2 AAV-based Gene Therapy Products Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AAV-BASED GENE THERAPY PRODUCTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AAV-based Gene Therapy Products Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global AAV-based Gene Therapy Products Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AAV-BASED GENE THERAPY PRODUCTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AAV-based Gene Therapy Products Product Life Cycle
3.3 Global AAV-based Gene Therapy Products Sales by Manufacturers (2020-2025)
3.4 Global AAV-based Gene Therapy Products Revenue Market Share by Manufacturers (2020-2025)
3.5 AAV-based Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global AAV-based Gene Therapy Products Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 AAV-based Gene Therapy Products Market Competitive Situation and Trends
3.8.1 AAV-based Gene Therapy Products Market Concentration Rate
3.8.2 Global 5 and 10 Largest AAV-based Gene Therapy Products Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AAV-BASED GENE THERAPY PRODUCTS INDUSTRY CHAIN ANALYSIS
4.1 AAV-based Gene Therapy Products Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AAV-BASED GENE THERAPY PRODUCTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AAV-based Gene Therapy Products Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to AAV-based Gene Therapy Products Market
5.7 ESG Ratings of Leading Companies
6 AAV-BASED GENE THERAPY PRODUCTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AAV-based Gene Therapy Products Sales Market Share by Type (2020-2025)
6.3 Global AAV-based Gene Therapy Products Market Size Market Share by Type (2020-2025)
6.4 Global AAV-based Gene Therapy Products Price by Type (2020-2025)
7 AAV-BASED GENE THERAPY PRODUCTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AAV-based Gene Therapy Products Market Sales by Application (2020-2025)
7.3 Global AAV-based Gene Therapy Products Market Size (M USD) by Application (2020-2025)
7.4 Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
8 AAV-BASED GENE THERAPY PRODUCTS MARKET SALES BY REGION
8.1 Global AAV-based Gene Therapy Products Sales by Region
8.1.1 Global AAV-based Gene Therapy Products Sales by Region
8.1.2 Global AAV-based Gene Therapy Products Sales Market Share by Region
8.2 Global AAV-based Gene Therapy Products Market Size by Region
8.2.1 Global AAV-based Gene Therapy Products Market Size by Region
8.2.2 Global AAV-based Gene Therapy Products Market Size Market Share by Region
8.3 North America
8.3.1 North America AAV-based Gene Therapy Products Sales by Country
8.3.2 North America AAV-based Gene Therapy Products Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe AAV-based Gene Therapy Products Sales by Country
8.4.2 Europe AAV-based Gene Therapy Products Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific AAV-based Gene Therapy Products Sales by Region
8.5.2 Asia Pacific AAV-based Gene Therapy Products Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America AAV-based Gene Therapy Products Sales by Country
8.6.2 South America AAV-based Gene Therapy Products Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa AAV-based Gene Therapy Products Sales by Region
8.7.2 Middle East and Africa AAV-based Gene Therapy Products Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AAV-BASED GENE THERAPY PRODUCTS MARKET PRODUCTION BY REGION
9.1 Global Production of AAV-based Gene Therapy Products by Region(2020-2025)
9.2 Global AAV-based Gene Therapy Products Revenue Market Share by Region (2020-2025)
9.3 Global AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America AAV-based Gene Therapy Products Production
9.4.1 North America AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.4.2 North America AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe AAV-based Gene Therapy Products Production
9.5.1 Europe AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.5.2 Europe AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan AAV-based Gene Therapy Products Production (2020-2025)
9.6.1 Japan AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.6.2 Japan AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China AAV-based Gene Therapy Products Production (2020-2025)
9.7.1 China AAV-based Gene Therapy Products Production Growth Rate (2020-2025)
9.7.2 China AAV-based Gene Therapy Products Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 uniQure
10.1.1 uniQure Basic Information
10.1.2 uniQure AAV-based Gene Therapy Products Product Overview
10.1.3 uniQure AAV-based Gene Therapy Products Product Market Performance
10.1.4 uniQure Business Overview
10.1.5 uniQure SWOT Analysis
10.1.6 uniQure Recent Developments
10.2 Spark Therapeutics
10.2.1 Spark Therapeutics Basic Information
10.2.2 Spark Therapeutics AAV-based Gene Therapy Products Product Overview
10.2.3 Spark Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.2.4 Spark Therapeutics Business Overview
10.2.5 Spark Therapeutics SWOT Analysis
10.2.6 Spark Therapeutics Recent Developments
10.3 AveXis (Novartis)
10.3.1 AveXis (Novartis) Basic Information
10.3.2 AveXis (Novartis) AAV-based Gene Therapy Products Product Overview
10.3.3 AveXis (Novartis) AAV-based Gene Therapy Products Product Market Performance
10.3.4 AveXis (Novartis) Business Overview
10.3.5 AveXis (Novartis) SWOT Analysis
10.3.6 AveXis (Novartis) Recent Developments
10.4 PTC Therapeutics
10.4.1 PTC Therapeutics Basic Information
10.4.2 PTC Therapeutics AAV-based Gene Therapy Products Product Overview
10.4.3 PTC Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.4.4 PTC Therapeutics Business Overview
10.4.5 PTC Therapeutics Recent Developments
10.5 BioMarin
10.5.1 BioMarin Basic Information
10.5.2 BioMarin AAV-based Gene Therapy Products Product Overview
10.5.3 BioMarin AAV-based Gene Therapy Products Product Market Performance
10.5.4 BioMarin Business Overview
10.5.5 BioMarin Recent Developments
10.6 Sarepta Therapeutics
10.6.1 Sarepta Therapeutics Basic Information
10.6.2 Sarepta Therapeutics AAV-based Gene Therapy Products Product Overview
10.6.3 Sarepta Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.6.4 Sarepta Therapeutics Business Overview
10.6.5 Sarepta Therapeutics Recent Developments
10.7 Roche
10.7.1 Roche Basic Information
10.7.2 Roche AAV-based Gene Therapy Products Product Overview
10.7.3 Roche AAV-based Gene Therapy Products Product Market Performance
10.7.4 Roche Business Overview
10.7.5 Roche Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer AAV-based Gene Therapy Products Product Overview
10.8.3 Pfizer AAV-based Gene Therapy Products Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 CSL Behring
10.9.1 CSL Behring Basic Information
10.9.2 CSL Behring AAV-based Gene Therapy Products Product Overview
10.9.3 CSL Behring AAV-based Gene Therapy Products Product Market Performance
10.9.4 CSL Behring Business Overview
10.9.5 CSL Behring Recent Developments
10.10 Sangamo Therapeutics
10.10.1 Sangamo Therapeutics Basic Information
10.10.2 Sangamo Therapeutics AAV-based Gene Therapy Products Product Overview
10.10.3 Sangamo Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.10.4 Sangamo Therapeutics Business Overview
10.10.5 Sangamo Therapeutics Recent Developments
10.11 Biogen
10.11.1 Biogen Basic Information
10.11.2 Biogen AAV-based Gene Therapy Products Product Overview
10.11.3 Biogen AAV-based Gene Therapy Products Product Market Performance
10.11.4 Biogen Business Overview
10.11.5 Biogen Recent Developments
10.12 Freeline Therapeutics
10.12.1 Freeline Therapeutics Basic Information
10.12.2 Freeline Therapeutics AAV-based Gene Therapy Products Product Overview
10.12.3 Freeline Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.12.4 Freeline Therapeutics Business Overview
10.12.5 Freeline Therapeutics Recent Developments
10.13 Coave Therapeutics
10.13.1 Coave Therapeutics Basic Information
10.13.2 Coave Therapeutics AAV-based Gene Therapy Products Product Overview
10.13.3 Coave Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.13.4 Coave Therapeutics Business Overview
10.13.5 Coave Therapeutics Recent Developments
10.14 MeiraGTx
10.14.1 MeiraGTx Basic Information
10.14.2 MeiraGTx AAV-based Gene Therapy Products Product Overview
10.14.3 MeiraGTx AAV-based Gene Therapy Products Product Market Performance
10.14.4 MeiraGTx Business Overview
10.14.5 MeiraGTx Recent Developments
10.15 RegenxBio
10.15.1 RegenxBio Basic Information
10.15.2 RegenxBio AAV-based Gene Therapy Products Product Overview
10.15.3 RegenxBio AAV-based Gene Therapy Products Product Market Performance
10.15.4 RegenxBio Business Overview
10.15.5 RegenxBio Recent Developments
10.16 Asklepios Biopharmaceutical
10.16.1 Asklepios Biopharmaceutical Basic Information
10.16.2 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Overview
10.16.3 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Market Performance
10.16.4 Asklepios Biopharmaceutical Business Overview
10.16.5 Asklepios Biopharmaceutical Recent Developments
10.17 Audentes Therapeutics
10.17.1 Audentes Therapeutics Basic Information
10.17.2 Audentes Therapeutics AAV-based Gene Therapy Products Product Overview
10.17.3 Audentes Therapeutics AAV-based Gene Therapy Products Product Market Performance
10.17.4 Audentes Therapeutics Business Overview
10.17.5 Audentes Therapeutics Recent Developments
10.18 Neurophth
10.18.1 Neurophth Basic Information
10.18.2 Neurophth AAV-based Gene Therapy Products Product Overview
10.18.3 Neurophth AAV-based Gene Therapy Products Product Market Performance
10.18.4 Neurophth Business Overview
10.18.5 Neurophth Recent Developments
10.19 Belief BioMed
10.19.1 Belief BioMed Basic Information
10.19.2 Belief BioMed AAV-based Gene Therapy Products Product Overview
10.19.3 Belief BioMed AAV-based Gene Therapy Products Product Market Performance
10.19.4 Belief BioMed Business Overview
10.19.5 Belief BioMed Recent Developments
11 AAV-BASED GENE THERAPY PRODUCTS MARKET FORECAST BY REGION
11.1 Global AAV-based Gene Therapy Products Market Size Forecast
11.2 Global AAV-based Gene Therapy Products Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AAV-based Gene Therapy Products Market Size Forecast by Country
11.2.3 Asia Pacific AAV-based Gene Therapy Products Market Size Forecast by Region
11.2.4 South America AAV-based Gene Therapy Products Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of AAV-based Gene Therapy Products by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global AAV-based Gene Therapy Products Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of AAV-based Gene Therapy Products by Type (2026-2033)
12.1.2 Global AAV-based Gene Therapy Products Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of AAV-based Gene Therapy Products by Type (2026-2033)
12.2 Global AAV-based Gene Therapy Products Market Forecast by Application (2026-2033)
12.2.1 Global AAV-based Gene Therapy Products Sales (K Units) Forecast by Application
12.2.2 Global AAV-based Gene Therapy Products Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. AAV-based Gene Therapy Products Market Size Comparison by Region (M USD)
Table 5. Global AAV-based Gene Therapy Products Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global AAV-based Gene Therapy Products Sales Market Share by Manufacturers (2020-2025)
Table 7. Global AAV-based Gene Therapy Products Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global AAV-based Gene Therapy Products Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV-based Gene Therapy Products as of 2024)
Table 10. Global Market AAV-based Gene Therapy Products Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global AAV-based Gene Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. AAV-based Gene Therapy Products Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global AAV-based Gene Therapy Products Sales by Type (K Units)
Table 26. Global AAV-based Gene Therapy Products Market Size by Type (M USD)
Table 27. Global AAV-based Gene Therapy Products Sales (K Units) by Type (2020-2025)
Table 28. Global AAV-based Gene Therapy Products Sales Market Share by Type (2020-2025)
Table 29. Global AAV-based Gene Therapy Products Market Size (M USD) by Type (2020-2025)
Table 30. Global AAV-based Gene Therapy Products Market Size Share by Type (2020-2025)
Table 31. Global AAV-based Gene Therapy Products Price (USD/Unit) by Type (2020-2025)
Table 32. Global AAV-based Gene Therapy Products Sales (K Units) by Application
Table 33. Global AAV-based Gene Therapy Products Market Size by Application
Table 34. Global AAV-based Gene Therapy Products Sales by Application (2020-2025) & (K Units)
Table 35. Global AAV-based Gene Therapy Products Sales Market Share by Application (2020-2025)
Table 36. Global AAV-based Gene Therapy Products Market Size by Application (2020-2025) & (M USD)
Table 37. Global AAV-based Gene Therapy Products Market Share by Application (2020-2025)
Table 38. Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
Table 39. Global AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 40. Global AAV-based Gene Therapy Products Sales Market Share by Region (2020-2025)
Table 41. Global AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 42. Global AAV-based Gene Therapy Products Market Size Market Share by Region (2020-2025)
Table 43. North America AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 44. North America AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 45. Europe AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 46. Europe AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 49. South America AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 50. South America AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 53. Global AAV-based Gene Therapy Products Production (K Units) by Region(2020-2025)
Table 54. Global AAV-based Gene Therapy Products Revenue (US$ Million) by Region (2020-2025)
Table 55. Global AAV-based Gene Therapy Products Revenue Market Share by Region (2020-2025)
Table 56. Global AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. uniQure Basic Information
Table 62. uniQure AAV-based Gene Therapy Products Product Overview
Table 63. uniQure AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. uniQure Business Overview
Table 65. uniQure SWOT Analysis
Table 66. uniQure Recent Developments
Table 67. Spark Therapeutics Basic Information
Table 68. Spark Therapeutics AAV-based Gene Therapy Products Product Overview
Table 69. Spark Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Spark Therapeutics Business Overview
Table 71. Spark Therapeutics SWOT Analysis
Table 72. Spark Therapeutics Recent Developments
Table 73. AveXis (Novartis) Basic Information
Table 74. AveXis (Novartis) AAV-based Gene Therapy Products Product Overview
Table 75. AveXis (Novartis) AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. AveXis (Novartis) Business Overview
Table 77. AveXis (Novartis) SWOT Analysis
Table 78. AveXis (Novartis) Recent Developments
Table 79. PTC Therapeutics Basic Information
Table 80. PTC Therapeutics AAV-based Gene Therapy Products Product Overview
Table 81. PTC Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. PTC Therapeutics Business Overview
Table 83. PTC Therapeutics Recent Developments
Table 84. BioMarin Basic Information
Table 85. BioMarin AAV-based Gene Therapy Products Product Overview
Table 86. BioMarin AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BioMarin Business Overview
Table 88. BioMarin Recent Developments
Table 89. Sarepta Therapeutics Basic Information
Table 90. Sarepta Therapeutics AAV-based Gene Therapy Products Product Overview
Table 91. Sarepta Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sarepta Therapeutics Business Overview
Table 93. Sarepta Therapeutics Recent Developments
Table 94. Roche Basic Information
Table 95. Roche AAV-based Gene Therapy Products Product Overview
Table 96. Roche AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Roche Business Overview
Table 98. Roche Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer AAV-based Gene Therapy Products Product Overview
Table 101. Pfizer AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. CSL Behring Basic Information
Table 105. CSL Behring AAV-based Gene Therapy Products Product Overview
Table 106. CSL Behring AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. CSL Behring Business Overview
Table 108. CSL Behring Recent Developments
Table 109. Sangamo Therapeutics Basic Information
Table 110. Sangamo Therapeutics AAV-based Gene Therapy Products Product Overview
Table 111. Sangamo Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Sangamo Therapeutics Business Overview
Table 113. Sangamo Therapeutics Recent Developments
Table 114. Biogen Basic Information
Table 115. Biogen AAV-based Gene Therapy Products Product Overview
Table 116. Biogen AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Biogen Business Overview
Table 118. Biogen Recent Developments
Table 119. Freeline Therapeutics Basic Information
Table 120. Freeline Therapeutics AAV-based Gene Therapy Products Product Overview
Table 121. Freeline Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Freeline Therapeutics Business Overview
Table 123. Freeline Therapeutics Recent Developments
Table 124. Coave Therapeutics Basic Information
Table 125. Coave Therapeutics AAV-based Gene Therapy Products Product Overview
Table 126. Coave Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Coave Therapeutics Business Overview
Table 128. Coave Therapeutics Recent Developments
Table 129. MeiraGTx Basic Information
Table 130. MeiraGTx AAV-based Gene Therapy Products Product Overview
Table 131. MeiraGTx AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. MeiraGTx Business Overview
Table 133. MeiraGTx Recent Developments
Table 134. RegenxBio Basic Information
Table 135. RegenxBio AAV-based Gene Therapy Products Product Overview
Table 136. RegenxBio AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. RegenxBio Business Overview
Table 138. RegenxBio Recent Developments
Table 139. Asklepios Biopharmaceutical Basic Information
Table 140. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Overview
Table 141. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Asklepios Biopharmaceutical Business Overview
Table 143. Asklepios Biopharmaceutical Recent Developments
Table 144. Audentes Therapeutics Basic Information
Table 145. Audentes Therapeutics AAV-based Gene Therapy Products Product Overview
Table 146. Audentes Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Audentes Therapeutics Business Overview
Table 148. Audentes Therapeutics Recent Developments
Table 149. Neurophth Basic Information
Table 150. Neurophth AAV-based Gene Therapy Products Product Overview
Table 151. Neurophth AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Neurophth Business Overview
Table 153. Neurophth Recent Developments
Table 154. Belief BioMed Basic Information
Table 155. Belief BioMed AAV-based Gene Therapy Products Product Overview
Table 156. Belief BioMed AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Belief BioMed Business Overview
Table 158. Belief BioMed Recent Developments
Table 159. Global AAV-based Gene Therapy Products Sales Forecast by Region (2026-2033) & (K Units)
Table 160. Global AAV-based Gene Therapy Products Market Size Forecast by Region (2026-2033) & (M USD)
Table 161. North America AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 162. North America AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 163. Europe AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 164. Europe AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 165. Asia Pacific AAV-based Gene Therapy Products Sales Forecast by Region (2026-2033) & (K Units)
Table 166. Asia Pacific AAV-based Gene Therapy Products Market Size Forecast by Region (2026-2033) & (M USD)
Table 167. South America AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 168. South America AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 169. Middle East and Africa AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (Units)
Table 170. Middle East and Africa AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 171. Global AAV-based Gene Therapy Products Sales Forecast by Type (2026-2033) & (K Units)
Table 172. Global AAV-based Gene Therapy Products Market Size Forecast by Type (2026-2033) & (M USD)
Table 173. Global AAV-based Gene Therapy Products Price Forecast by Type (2026-2033) & (USD/Unit)
Table 174. Global AAV-based Gene Therapy Products Sales (K Units) Forecast by Application (2026-2033)
Table 175. Global AAV-based Gene Therapy Products Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. AAV-based Gene Therapy Products Market Size Comparison by Region (M USD)
Table 5. Global AAV-based Gene Therapy Products Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global AAV-based Gene Therapy Products Sales Market Share by Manufacturers (2020-2025)
Table 7. Global AAV-based Gene Therapy Products Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global AAV-based Gene Therapy Products Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV-based Gene Therapy Products as of 2024)
Table 10. Global Market AAV-based Gene Therapy Products Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global AAV-based Gene Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. AAV-based Gene Therapy Products Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global AAV-based Gene Therapy Products Sales by Type (K Units)
Table 26. Global AAV-based Gene Therapy Products Market Size by Type (M USD)
Table 27. Global AAV-based Gene Therapy Products Sales (K Units) by Type (2020-2025)
Table 28. Global AAV-based Gene Therapy Products Sales Market Share by Type (2020-2025)
Table 29. Global AAV-based Gene Therapy Products Market Size (M USD) by Type (2020-2025)
Table 30. Global AAV-based Gene Therapy Products Market Size Share by Type (2020-2025)
Table 31. Global AAV-based Gene Therapy Products Price (USD/Unit) by Type (2020-2025)
Table 32. Global AAV-based Gene Therapy Products Sales (K Units) by Application
Table 33. Global AAV-based Gene Therapy Products Market Size by Application
Table 34. Global AAV-based Gene Therapy Products Sales by Application (2020-2025) & (K Units)
Table 35. Global AAV-based Gene Therapy Products Sales Market Share by Application (2020-2025)
Table 36. Global AAV-based Gene Therapy Products Market Size by Application (2020-2025) & (M USD)
Table 37. Global AAV-based Gene Therapy Products Market Share by Application (2020-2025)
Table 38. Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
Table 39. Global AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 40. Global AAV-based Gene Therapy Products Sales Market Share by Region (2020-2025)
Table 41. Global AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 42. Global AAV-based Gene Therapy Products Market Size Market Share by Region (2020-2025)
Table 43. North America AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 44. North America AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 45. Europe AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 46. Europe AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 49. South America AAV-based Gene Therapy Products Sales by Country (2020-2025) & (K Units)
Table 50. South America AAV-based Gene Therapy Products Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa AAV-based Gene Therapy Products Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa AAV-based Gene Therapy Products Market Size by Region (2020-2025) & (M USD)
Table 53. Global AAV-based Gene Therapy Products Production (K Units) by Region(2020-2025)
Table 54. Global AAV-based Gene Therapy Products Revenue (US$ Million) by Region (2020-2025)
Table 55. Global AAV-based Gene Therapy Products Revenue Market Share by Region (2020-2025)
Table 56. Global AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China AAV-based Gene Therapy Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. uniQure Basic Information
Table 62. uniQure AAV-based Gene Therapy Products Product Overview
Table 63. uniQure AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. uniQure Business Overview
Table 65. uniQure SWOT Analysis
Table 66. uniQure Recent Developments
Table 67. Spark Therapeutics Basic Information
Table 68. Spark Therapeutics AAV-based Gene Therapy Products Product Overview
Table 69. Spark Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Spark Therapeutics Business Overview
Table 71. Spark Therapeutics SWOT Analysis
Table 72. Spark Therapeutics Recent Developments
Table 73. AveXis (Novartis) Basic Information
Table 74. AveXis (Novartis) AAV-based Gene Therapy Products Product Overview
Table 75. AveXis (Novartis) AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. AveXis (Novartis) Business Overview
Table 77. AveXis (Novartis) SWOT Analysis
Table 78. AveXis (Novartis) Recent Developments
Table 79. PTC Therapeutics Basic Information
Table 80. PTC Therapeutics AAV-based Gene Therapy Products Product Overview
Table 81. PTC Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. PTC Therapeutics Business Overview
Table 83. PTC Therapeutics Recent Developments
Table 84. BioMarin Basic Information
Table 85. BioMarin AAV-based Gene Therapy Products Product Overview
Table 86. BioMarin AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BioMarin Business Overview
Table 88. BioMarin Recent Developments
Table 89. Sarepta Therapeutics Basic Information
Table 90. Sarepta Therapeutics AAV-based Gene Therapy Products Product Overview
Table 91. Sarepta Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sarepta Therapeutics Business Overview
Table 93. Sarepta Therapeutics Recent Developments
Table 94. Roche Basic Information
Table 95. Roche AAV-based Gene Therapy Products Product Overview
Table 96. Roche AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Roche Business Overview
Table 98. Roche Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer AAV-based Gene Therapy Products Product Overview
Table 101. Pfizer AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. CSL Behring Basic Information
Table 105. CSL Behring AAV-based Gene Therapy Products Product Overview
Table 106. CSL Behring AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. CSL Behring Business Overview
Table 108. CSL Behring Recent Developments
Table 109. Sangamo Therapeutics Basic Information
Table 110. Sangamo Therapeutics AAV-based Gene Therapy Products Product Overview
Table 111. Sangamo Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Sangamo Therapeutics Business Overview
Table 113. Sangamo Therapeutics Recent Developments
Table 114. Biogen Basic Information
Table 115. Biogen AAV-based Gene Therapy Products Product Overview
Table 116. Biogen AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Biogen Business Overview
Table 118. Biogen Recent Developments
Table 119. Freeline Therapeutics Basic Information
Table 120. Freeline Therapeutics AAV-based Gene Therapy Products Product Overview
Table 121. Freeline Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Freeline Therapeutics Business Overview
Table 123. Freeline Therapeutics Recent Developments
Table 124. Coave Therapeutics Basic Information
Table 125. Coave Therapeutics AAV-based Gene Therapy Products Product Overview
Table 126. Coave Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Coave Therapeutics Business Overview
Table 128. Coave Therapeutics Recent Developments
Table 129. MeiraGTx Basic Information
Table 130. MeiraGTx AAV-based Gene Therapy Products Product Overview
Table 131. MeiraGTx AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. MeiraGTx Business Overview
Table 133. MeiraGTx Recent Developments
Table 134. RegenxBio Basic Information
Table 135. RegenxBio AAV-based Gene Therapy Products Product Overview
Table 136. RegenxBio AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. RegenxBio Business Overview
Table 138. RegenxBio Recent Developments
Table 139. Asklepios Biopharmaceutical Basic Information
Table 140. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product Overview
Table 141. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Asklepios Biopharmaceutical Business Overview
Table 143. Asklepios Biopharmaceutical Recent Developments
Table 144. Audentes Therapeutics Basic Information
Table 145. Audentes Therapeutics AAV-based Gene Therapy Products Product Overview
Table 146. Audentes Therapeutics AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Audentes Therapeutics Business Overview
Table 148. Audentes Therapeutics Recent Developments
Table 149. Neurophth Basic Information
Table 150. Neurophth AAV-based Gene Therapy Products Product Overview
Table 151. Neurophth AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Neurophth Business Overview
Table 153. Neurophth Recent Developments
Table 154. Belief BioMed Basic Information
Table 155. Belief BioMed AAV-based Gene Therapy Products Product Overview
Table 156. Belief BioMed AAV-based Gene Therapy Products Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Belief BioMed Business Overview
Table 158. Belief BioMed Recent Developments
Table 159. Global AAV-based Gene Therapy Products Sales Forecast by Region (2026-2033) & (K Units)
Table 160. Global AAV-based Gene Therapy Products Market Size Forecast by Region (2026-2033) & (M USD)
Table 161. North America AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 162. North America AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 163. Europe AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 164. Europe AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 165. Asia Pacific AAV-based Gene Therapy Products Sales Forecast by Region (2026-2033) & (K Units)
Table 166. Asia Pacific AAV-based Gene Therapy Products Market Size Forecast by Region (2026-2033) & (M USD)
Table 167. South America AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (K Units)
Table 168. South America AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 169. Middle East and Africa AAV-based Gene Therapy Products Sales Forecast by Country (2026-2033) & (Units)
Table 170. Middle East and Africa AAV-based Gene Therapy Products Market Size Forecast by Country (2026-2033) & (M USD)
Table 171. Global AAV-based Gene Therapy Products Sales Forecast by Type (2026-2033) & (K Units)
Table 172. Global AAV-based Gene Therapy Products Market Size Forecast by Type (2026-2033) & (M USD)
Table 173. Global AAV-based Gene Therapy Products Price Forecast by Type (2026-2033) & (USD/Unit)
Table 174. Global AAV-based Gene Therapy Products Sales (K Units) Forecast by Application (2026-2033)
Table 175. Global AAV-based Gene Therapy Products Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of AAV-based Gene Therapy Products
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AAV-based Gene Therapy Products Market Size (M USD), 2024-2033
Figure 5. Global AAV-based Gene Therapy Products Market Size (M USD) (2020-2033)
Figure 6. Global AAV-based Gene Therapy Products Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AAV-based Gene Therapy Products Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global AAV-based Gene Therapy Products Product Life Cycle
Figure 13. AAV-based Gene Therapy Products Sales Share by Manufacturers in 2024
Figure 14. Global AAV-based Gene Therapy Products Revenue Share by Manufacturers in 2024
Figure 15. AAV-based Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market AAV-based Gene Therapy Products Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by AAV-based Gene Therapy Products Revenue in 2024
Figure 18. Industry Chain Map of AAV-based Gene Therapy Products
Figure 19. Global AAV-based Gene Therapy Products Market PEST Analysis
Figure 20. Global AAV-based Gene Therapy Products Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global AAV-based Gene Therapy Products Market Share by Type
Figure 27. Sales Market Share of AAV-based Gene Therapy Products by Type (2020-2025)
Figure 28. Sales Market Share of AAV-based Gene Therapy Products by Type in 2024
Figure 29. Market Size Share of AAV-based Gene Therapy Products by Type (2020-2025)
Figure 30. Market Size Share of AAV-based Gene Therapy Products by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global AAV-based Gene Therapy Products Market Share by Application
Figure 33. Global AAV-based Gene Therapy Products Sales Market Share by Application (2020-2025)
Figure 34. Global AAV-based Gene Therapy Products Sales Market Share by Application in 2024
Figure 35. Global AAV-based Gene Therapy Products Market Share by Application (2020-2025)
Figure 36. Global AAV-based Gene Therapy Products Market Share by Application in 2024
Figure 37. Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
Figure 38. Global AAV-based Gene Therapy Products Sales Market Share by Region (2020-2025)
Figure 39. Global AAV-based Gene Therapy Products Market Size Market Share by Region (2020-2025)
Figure 40. North America AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 43. North America AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 45. U.S. AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada AAV-based Gene Therapy Products Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada AAV-based Gene Therapy Products Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico AAV-based Gene Therapy Products Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico AAV-based Gene Therapy Products Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 53. Europe AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 55. Germany AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 66. Asia Pacific AAV-based Gene Therapy Products Sales Market Share by Region in 2024
Figure 67. Asia Pacific AAV-based Gene Therapy Products Market Size Market Share by Region in 2024
Figure 68. China AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 79. South America AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 80. South America AAV-based Gene Therapy Products Market Size and Growth Rate (M USD)
Figure 81. South America AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 82. Brazil AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa AAV-based Gene Therapy Products Sales Market Share by Region in 2024
Figure 90. Middle East and Africa AAV-based Gene Therapy Products Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa AAV-based Gene Therapy Products Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global AAV-based Gene Therapy Products Production Market Share by Region (2020-2025)
Figure 103. North America AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 106. China AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 107. Global AAV-based Gene Therapy Products Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global AAV-based Gene Therapy Products Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global AAV-based Gene Therapy Products Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global AAV-based Gene Therapy Products Market Share Forecast by Type (2026-2033)
Figure 111. Global AAV-based Gene Therapy Products Sales Forecast by Application (2026-2033)
Figure 112. Global AAV-based Gene Therapy Products Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of AAV-based Gene Therapy Products
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AAV-based Gene Therapy Products Market Size (M USD), 2024-2033
Figure 5. Global AAV-based Gene Therapy Products Market Size (M USD) (2020-2033)
Figure 6. Global AAV-based Gene Therapy Products Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AAV-based Gene Therapy Products Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global AAV-based Gene Therapy Products Product Life Cycle
Figure 13. AAV-based Gene Therapy Products Sales Share by Manufacturers in 2024
Figure 14. Global AAV-based Gene Therapy Products Revenue Share by Manufacturers in 2024
Figure 15. AAV-based Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market AAV-based Gene Therapy Products Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by AAV-based Gene Therapy Products Revenue in 2024
Figure 18. Industry Chain Map of AAV-based Gene Therapy Products
Figure 19. Global AAV-based Gene Therapy Products Market PEST Analysis
Figure 20. Global AAV-based Gene Therapy Products Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global AAV-based Gene Therapy Products Market Share by Type
Figure 27. Sales Market Share of AAV-based Gene Therapy Products by Type (2020-2025)
Figure 28. Sales Market Share of AAV-based Gene Therapy Products by Type in 2024
Figure 29. Market Size Share of AAV-based Gene Therapy Products by Type (2020-2025)
Figure 30. Market Size Share of AAV-based Gene Therapy Products by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global AAV-based Gene Therapy Products Market Share by Application
Figure 33. Global AAV-based Gene Therapy Products Sales Market Share by Application (2020-2025)
Figure 34. Global AAV-based Gene Therapy Products Sales Market Share by Application in 2024
Figure 35. Global AAV-based Gene Therapy Products Market Share by Application (2020-2025)
Figure 36. Global AAV-based Gene Therapy Products Market Share by Application in 2024
Figure 37. Global AAV-based Gene Therapy Products Sales Growth Rate by Application (2020-2025)
Figure 38. Global AAV-based Gene Therapy Products Sales Market Share by Region (2020-2025)
Figure 39. Global AAV-based Gene Therapy Products Market Size Market Share by Region (2020-2025)
Figure 40. North America AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 43. North America AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 45. U.S. AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada AAV-based Gene Therapy Products Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada AAV-based Gene Therapy Products Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico AAV-based Gene Therapy Products Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico AAV-based Gene Therapy Products Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 53. Europe AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 55. Germany AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 66. Asia Pacific AAV-based Gene Therapy Products Sales Market Share by Region in 2024
Figure 67. Asia Pacific AAV-based Gene Therapy Products Market Size Market Share by Region in 2024
Figure 68. China AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 79. South America AAV-based Gene Therapy Products Sales Market Share by Country in 2024
Figure 80. South America AAV-based Gene Therapy Products Market Size and Growth Rate (M USD)
Figure 81. South America AAV-based Gene Therapy Products Market Size Market Share by Country in 2024
Figure 82. Brazil AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa AAV-based Gene Therapy Products Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa AAV-based Gene Therapy Products Sales Market Share by Region in 2024
Figure 90. Middle East and Africa AAV-based Gene Therapy Products Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa AAV-based Gene Therapy Products Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa AAV-based Gene Therapy Products Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa AAV-based Gene Therapy Products Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global AAV-based Gene Therapy Products Production Market Share by Region (2020-2025)
Figure 103. North America AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 106. China AAV-based Gene Therapy Products Production (K Units) Growth Rate (2020-2025)
Figure 107. Global AAV-based Gene Therapy Products Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global AAV-based Gene Therapy Products Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global AAV-based Gene Therapy Products Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global AAV-based Gene Therapy Products Market Share Forecast by Type (2026-2033)
Figure 111. Global AAV-based Gene Therapy Products Sales Forecast by Application (2026-2033)
Figure 112. Global AAV-based Gene Therapy Products Market Share Forecast by Application (2026-2033)
